These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21139590)

  • 21. Manufacturers' recommendations for handling spilled hazardous drugs.
    Gonzalez R; Massoomi FF
    Am J Health Syst Pharm; 2010 Dec; 67(23):1985-6. PubMed ID: 21098367
    [No Abstract]   [Full Text] [Related]  

  • 22. Protect pharmaceutical innovation.
    Musselwhite LW; Andrews J
    Science; 2010 Jun; 328(5984):1354; author reply 1354-5. PubMed ID: 20538934
    [No Abstract]   [Full Text] [Related]  

  • 23. Intellectual property. Fixing the legal framework for pharmaceutical research.
    Knowles SM
    Science; 2010 Feb; 327(5969):1083-4. PubMed ID: 20150445
    [No Abstract]   [Full Text] [Related]  

  • 24. How to ensure our readers' trust: the proper attribution of authors and contributors.
    Liesegang TJ; Albert DM; Schachat AP
    Am J Ophthalmol; 2008 Sep; 146(3):337-40. PubMed ID: 18724976
    [No Abstract]   [Full Text] [Related]  

  • 25. Out in the open.
    Nat Biotechnol; 2005 Feb; 23(2):153. PubMed ID: 15696130
    [No Abstract]   [Full Text] [Related]  

  • 26. Justices expand rights to experiment with patented drugs.
    Pollack A
    N Y Times Web; 2005 Jun; ():C1, C8. PubMed ID: 15966121
    [No Abstract]   [Full Text] [Related]  

  • 27. Standardization in synthetic biology: an engineering discipline coming of age.
    Decoene T; De Paepe B; Maertens J; Coussement P; Peters G; De Maeseneire SL; De Mey M
    Crit Rev Biotechnol; 2018 Aug; 38(5):647-656. PubMed ID: 28954542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Student rally. Med school attendees write ethics code on drug firms.
    Romano M
    Mod Healthc; 2002 May; 32(19):24, 26. PubMed ID: 12038157
    [No Abstract]   [Full Text] [Related]  

  • 29. Scientific Opinion on Risk Assessment of Synthetic Biology.
    Epstein MM; Vermeire T
    Trends Biotechnol; 2016 Aug; 34(8):601-603. PubMed ID: 27234301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biotechnology products and university-based science.
    Sobolski GK
    JAMA; 2005 Jun; 293(23):2862; author reply 2863. PubMed ID: 15956629
    [No Abstract]   [Full Text] [Related]  

  • 31. Food and Drug Administration public hearing on the draft guidance for exception from informed consent requirements for emergency research: testimony of Novo Nordisk.
    Weiskopf RB;
    Acad Emerg Med; 2007 Apr; 14(4):e71-3. PubMed ID: 17322571
    [No Abstract]   [Full Text] [Related]  

  • 32. University-based science and biotechnology products: defining the boundaries of intellectual property.
    Kesselheim AS; Avorn J
    JAMA; 2005 Feb; 293(7):850-4. PubMed ID: 15713775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biotechnology products and university-based science.
    Korn D; Heinig SJ
    JAMA; 2005 Jun; 293(23):2862-3; author reply 2863. PubMed ID: 15956628
    [No Abstract]   [Full Text] [Related]  

  • 34. The distortion of commercial research reported in the peer-reviewed literature.
    Liesegang TJ
    Can J Ophthalmol; 2009 Aug; 44(4):367-9. PubMed ID: 19606153
    [No Abstract]   [Full Text] [Related]  

  • 35. Will the RACE for Children Act lead to new treatments for pediatric cancer?
    Fink JL
    Cancer; 2017 Jan; 123(2):189. PubMed ID: 28067946
    [No Abstract]   [Full Text] [Related]  

  • 36. AAFP supports improvement, not ban, on direct-to-consumer prescription drug ads.
    Kellerman R;
    Ann Fam Med; 2007; 5(2):180-1. PubMed ID: 17389544
    [No Abstract]   [Full Text] [Related]  

  • 37. Staying sober about science.
    Carlson R
    Hastings Cent Rep; 2011; 41(4):22-5. PubMed ID: 21845918
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmaceutical GMPs.
    Bobrowicz G
    Qual Assur; 1994 Jun; 3(2):138-48. PubMed ID: 7804629
    [No Abstract]   [Full Text] [Related]  

  • 39. Protection for manufacturing, not research.
    Nat Rev Drug Discov; 2003 Oct; 2(10):766. PubMed ID: 14579809
    [No Abstract]   [Full Text] [Related]  

  • 40. Drug firms back-pedal on direct advertising.
    Nature; 2005 Aug; 436(7053):910-1. PubMed ID: 16107811
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.